1. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
- Author
-
Holman, Rury R, Coleman, Ruth L, Chan, Juliana C N, Chiasson, Jean-Louis, Feng, Huimei, Ge, Junbo, Gerstein, Hertzel C, Gray, Richard, Huo, Yong, Lang, Zhihui, McMurray, John J, Rydén, Lars, Schröder, Stefan, Sun, Yihong, Theodorakis, Michael J, Tendera, Michal, Tucker, Lynne, Tuomilehto, Jaakko, Wei, Yidong, Yang, Wenying, Wang, Duolao, Hu, Dayi, Pan, Changyu, Keenan, Joanne, Milton, Joanne, Doran, Zoe, Bray, Chris, Rouleau, Jean L, Collier, Jane, Pocock, Stuart, Standl, Eberhard, Swedberg, Karl, Weng, Jianping, Zhao, Dong, Petrie, Mark C, Connolly, Eugene, Jhund, Pardeep, MacDonald, Michael, Myles, Rachel C, Bai, Rong, Li, Jing, Liu, Zhaoping, Liu, Zhenyu, Peng, Dantao, Tong, Qiguang, Wang, Chunxue, Yan, Xiaowei, Zhang, Yuqing, Zhou, Jingmin, Sattar, Naveed, Fisher, Miles, Petrie, John R, Bethel, M Angelyn, Xu, Wen, Hearn, Sarah, Kappai, Anurag, Su, Shu-Yi, Liyanage, Winitha, Paul, Sanjoy, Pozzi, Emanuela, Ring, Arne, Athwal, Rajbir, Batra, Priyanka, Ferch, Andrea, Groves, Natasha, Kennedy, Irene, Nawalaniec, Olga, Patel, Yash, Roberts, Rachel, Rush, Victoria, Starrett, Jayne, Tang, Jennifer, Bi, Jing, Jiang, Zhe, Wei, Hua, Wei, Xiaoshuai, Zhang, Xuan, Yin, Jun, Sun, Yu, Hu, Rong, Liu, Yang, Long, Jianjing, Long, Yuefeng, Qiao, Guofang, Qiao, Haoyi, Sun, Xiaochun, Zhang, Yucheng, Zhou, Jing, Wang, Bangning, Chen, Bin, Deng, Lili, Han, Xiaoning, Hu, Taohong, Hua, Qi, Huo, Yanming, Li, Hongmei, Li, Hongwei, Liu, Lihua, Lu, Juming, Ma, Changsheng, Peng, Jianjun, Pi, Lin, Wang, Bin, Wei, Guanglin, Yang, Ming, Zhang, Shuyang, Zhang, Likun, Zhao, Xia, Zhou, Yujie, Shi, Libin, Wang, Mingsheng, Wu, Lirong, Han, Lei, Liao, Ronghong, Ran, Boli, She, Qiang, Tan, Jiancong, Xia, Mei, Yang, Chengming, Chen, Lianglong, Xiong, Shangquan, Yu, Ling, Pu, Xiaodong, Wang, Yan, Xie, Qiang, Chen, Cibin, Chen, Jiyan, Dong, Yugang, Wu, Zhaohui, Yuan, Yong, Zhou, Wanxing, Zhou, Shuxian, Chen, Xiaochao, Wu, Chun, Zhang, Aidong, Li, Zicheng, Lai, Shayi, Yang, Jin, Wei, Jinru, Kuang, Riyu, Zhao, Zilin, Zhong, Guoqiang, Cao, Xufen, Hao, Yuming, Liu, Gang, Wang, Dongmei, Fang, Hui, Kong, Lingjun, Li, Haitao, Wang, Changqing, Wang, Li'na, Li, Xueqi, Dong, Pingshuan, Zhang, Shouyan, Liu, Xincan, Zhao, Yulan, Liu, Hengliang, Gu, Ye, Liao, Yuhua, Su, Xi, Wang, Daowen, Wang, Hairong, Yang, Bo, Guo, Ying, Ouyang, Ding'an, Yang, Tianlun, Zhang, Yumin, Han, Yajun, Lin, Xuefeng, Zhao, Ruiping, Man, Ronghai, Bian, Rongwen, Biao, Xu, Hasimu, Buaijiaer, Jin, Hui, Liu, Ping, Yu, Jiangyi, Zhang, Hang, Xu, Chongli, Guo, Yan, Lv, Ke, Tao, Yijia, Xu, Xin, Yang, Zhenyu, Li, Dongye, Qi, Chunmei, Zhang, Guohui, Gu, Xiang, Hong, Lang, Hu, Ling, Li, Juxiang, Yang, Ping, Liu, Bin, Wang, Gang, Lin, Hailong, Liu, Jun, Zhang, Shuying, Han, Ping, Jin, Yuanzhe, Li, Ling, Li, Zhanquan, Luan, Hong, Song, Mei, Xue, Li, Hua, Yu, Liu, Dongwu, Yuan, Zuyi, Ye, Jixian, Gao, Feng, Feng, Jinhua, Wang, A'li, Ye, Shengming, Li, Xiaoyan, Su, Guohai, Zhang, Shufang, Hou, Zishan, Jiang, Wenbin, Zhou, Changyong, Wang, Yanping, Qi, Wenbo, Bao, Xiaomei, Feng, Bo, Gong, Hui, Gu, Shuiming, Gu, Mingjun, Guo, Xingui, He, Ben, Huang, Ying, Jiang, Jinfa, Jiang, Yifeng, Jin, Huigen, Li, Yuehua, Liu, Qiliang, Lu, Guoping, Miao, Peizhi, Qin, Yongwen, Wang, Bin, Wang, Yuanming, Wu, Shiyao, Xu, Yawei, Ma, Jin, Chen, Xiaoping, Liu, Xiumin, Tang, Jianing, Wang, Jingping, Chen, Xiaoping, Tao, Jianhong, Zhang, Jun, Zhang, Tingjie, Li, Decai, Du, Xinping, Jiang, Tiemin, Lin, Jingna, Lu, Chengzhi, Ma, Hongjun, Gao, Bo, Guo, Xukun, Li, Tong, Zheng, Shaoxiong, Li, Zhongcheng, Zhao, Shuwu, Qiu, Qiang, Li, Kaili, Liu, Junming, Tang, Baopeng, Yuan, Zhanjun, Zhou, Jianhua, Bai, Wenwei, Guo, Tao, Zhang, Ge, Zhang, Hong, Hao, Yinglu, Fu, Guosheng, Tang, Lijiang, and Chen, Jialun
- Abstract
The effect of the α-glucosidase inhibitor acarbose on cardiovascular outcomes in patients with coronary heart disease and impaired glucose tolerance is unknown. We aimed to assess whether acarbose could reduce the frequency of cardiovascular events in Chinese patients with established coronary heart disease and impaired glucose tolerance, and whether the incidence of type 2 diabetes could be reduced.
- Published
- 2017
- Full Text
- View/download PDF